Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01036074 · ClinicalTrials.gov registry record

Reward Processing in Cocaine Addiction

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
90
Enrollment target

NCT01036074 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01036074 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
90 participants
Enrollment target

Study Summary

Background: \- Cocaine affects the brain's ability to process information. However, different people respond to cocaine in different ways, and differences in brain structure and function may affect how cocaine alters brain activity. By using functional magnetic resonance imaging (fMRI) to monitor brain activity during tasks that provide simple rewards, researchers hope to better understand how the brain responds to rewards and how this response is affected by drugs like cocaine. Objectives: * To determine the effect of cocaine administration on the reward experience in cocaine-dependent individuals. * To study genetic and personality factors that may contribute to cocaine dependence. Eligibility: \- Individuals between 18 and 45 years of age who either are cocaine-dependent and not seeking treatment or are healthy volunteers. Design: * Participants will be asked to avoid consuming alcohol and restrict consumption of caffeine prior to the study. Participants provide urine and breath samples to be tested for chemicals that may interfere with the study. * All participants will complete a training session and at least one fMRI scanning session. During the training session, participants will be introduced to the reward tasks and MRI equipment. * Healthy volunteers will have a single fMRI session that will involve reward tasks to be completed during the scanning. Rewards will include small amounts of fruit juice and the opportunity to win money. * Cocaine-dependent participants will have a training session and three experimental sessions including 1) a mock MRI scan to test cocaine tolerance, 2) one fMRI scan with reward tasks after administration of IV cocaine, and 3) one fMRI scan with reward tasks after administration of IV placebo (saline solution). Rewards will include small amounts of fruit juice and the opportunity to win money. * In addition to the scans, participants will provide a blood sample for further study and will answer questionnaires provided by t

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2005-03-17
Est. Completion 2013-04-08

What the Registry Record Tells You About NCT01036074

The ClinicalTrials.gov registry entry for NCT01036074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01036074 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01036074 about?

NCT01036074 is a clinical study titled "Reward Processing in Cocaine Addiction". Background: \- Cocaine affects the brain's ability to process information. However, different people respond to cocaine in different ways, and differences in brain structure and function may affect how cocaine alters brain activity. By using functional magnetic resonance imaging (fMRI) to monitor b...

What is the current status of trial NCT01036074?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2005-03-17. Estimated completion is 2013-04-08.

Who is sponsoring clinical trial NCT01036074?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.